The Patient’s Perspective: Diagnosing and Treating HS

August 29, 2024

Talking About Mental Health With HS Patients

August 26, 2024

Ushering in a New Era for HS Patients

August 26, 2024

MoonLake Immunotherapeutics Receives Regulatory Greenlights for Phase 3 Program of Sonelokimab in PsA

June 10, 2024

AARS Offers Social Toolkit to Help Spread #AcneFacts During National Acne Awareness Month

May 28, 2024

News You Can Use: First Global HS Atlas Now Available From GHiSA, ILDS

May 28, 2024

Phase 3 Data: Bimekizumab Earns High Marks in HS

May 23, 2024

HS Pipeline Watch: MoonLake Immunotherapeutics’ Sonelokimab Advances to Phase 3

May 16, 2024

Adalimumab Improves Hematologic Abnormalities in HS Patients

May 9, 2024

Study: Stigma Affects Quality of Life for Kids With Chronic Skin Diseases

April 24, 2024

FDA Accepts UCB’s sBLA for 2 mL Bimzelx Device

April 22, 2024

FDA Accepts UCB’s sBLA for Bimzelx in HS

April 22, 2024